{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:30:16Z","timestamp":1753893016959,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hepatitis B virus (HBV) is a major cause of chronic liver disease. While the hepatitis B vaccine has been proven effective in preventing HBV infection, concerns regarding Events Supposedly Attributable to Vaccination or Immunization (ESAVI) persist. This study aims to utilize the Vaccine Adverse Event Reporting System (VAERS) database to explore potential associations between the hepatitis B vaccine and musculoskeletal system AEs, providing a scientific basis for vaccine safety evaluations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study analyzed VAERS data from 1990 to 2024, focusing on 76,887 reports associated with hepatitis B vaccines. Disproportionality analysis methods, such as the Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR), were applied to identify the distribution and signal strength of musculoskeletal-related AEs. Furthermore, multivariable logistic regression analysis was conducted to explore association between patients with HBV vaccine and death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Musculoskeletal system ESAVIs constituted a significant portion of all reports, including tendon fibrosis (ROR\u202f=\u202f251.82), myofascitis (ROR\u202f=\u202f107.51), fasciitis (ROR\u202f=\u202f71.52), and osteoarthritis (ROR\u202f=\u202f7.56). Tendon fibrosis demonstrated the strongest association, potentially linked to chronic inflammatory responses and abnormal tissue repair induced by aluminum adjuvants. Most AEs occurred within 30\u202fdays post-vaccination, though some, such as myofascitis, had a longer mean onset time (1,671\u202fdays), reflecting the slow-release properties of aluminum adjuvants. In multivariable logistic regression analysis, we concluded that male and combination vaccine treatment were risk factors while age from18-64\u202fyears was a protective factors of death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identifies potential associations between hepatitis B vaccination and musculoskeletal system AEs, emphasizing the need for thorough pre-vaccination assessments and post-vaccination monitoring for high-risk individuals.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1560973","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:43:26Z","timestamp":1746186206000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system"],"prefix":"10.3389","volume":"13","author":[{"given":"Yiqing","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bukun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1016\/j.vaccine.2022.08.036","article-title":"Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults","volume":"40","author":"Fraiman","year":"2022","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.medmal.2019.09.012","article-title":"Aluminum and vaccines: current state of knowledge","volume":"50","author":"Goull\u00e9","year":"2020","journal-title":"Med Mal Infect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/vaccines10050819","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1002\/jmv.27214","article-title":"Safety of COVID-19 vaccines","volume":"93","author":"Al Khames Aga","year":"2021","journal-title":"J Med Virol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdcr.2022.11.038","article-title":"Eosinophilic fasciitis following SARS-CoV-2 vaccination","volume":"36","author":"Antu\u00f1a","year":"2023","journal-title":"JAAD Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"921760","DOI":"10.3389\/fphar.2022.921760","article-title":"Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: gaining insight through the VAERS","volume":"13","author":"Yan","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1338862","DOI":"10.3389\/fpubh.2023.1338862","article-title":"Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS)","volume":"11","author":"Shin","year":"2023","journal-title":"Front Public Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1369384","DOI":"10.3389\/fphar.2024.1369384","article-title":"Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2023.11.076","article-title":"Mining and analysis of adverse event signals of Cariprazine based on the real-world data of FAERS database","volume":"347","author":"Zhu","year":"2024","journal-title":"J Affect Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"940047","DOI":"10.3389\/fimmu.2022.940047","article-title":"Vaccine adjuvants to engage the cross-presentation pathway","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"116273","DOI":"10.1016\/j.bcp.2024.116273","article-title":"Relaxin as a treatment for musculoskeletal fibrosis: what we know and future directions","volume":"225","author":"Nourmahnad","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1038\/s41598-023-30336-1","article-title":"Advances on the early cellular events occurring upon exposure of human macrophages to aluminum oxyhydroxide adjuvant","volume":"13","author":"Masson","year":"2023","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.etap.2020.103404","article-title":"Distinctive cellular response to aluminum based adjuvants","volume":"78","author":"Nies","year":"2020","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jceh.2021.12.003","article-title":"Vaccination in chronic liver disease: an update","volume":"12","author":"Alukal","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/08923973.2022.2121925","article-title":"Is hepatitis-B immunization effective during chronic liver fibrosis? Investigation of secretory and cellular immune responses on an experimental model","volume":"45","author":"Kayhan","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/fcp.12999","article-title":"Challenges and opportunities of medicines for treating tendon inflammation and fibrosis: a comprehensive and mechanistic review","volume":"38","author":"Najafi","year":"2024","journal-title":"Fundament Clin Pharma"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/cas.15714","article-title":"Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events","volume":"114","author":"Matsumura","year":"2023","journal-title":"Cancer Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102603","DOI":"10.1016\/j.autrev.2020.102603","article-title":"Gulf war illness, post-HPV vaccination syndrome, and Macrophagic Myofasciitis. Similar disabling conditions possibly linked to vaccine-induced autoimmune dysautonomia","volume":"19","author":"Martinez-Lavin","year":"2020","journal-title":"Autoimmun Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/toxics12070491","article-title":"Widespread myalgia and chronic fatigue: phagocytes from Macrophagic Myofasciitis patients exposed to aluminum Oxyhydroxide-Adjuvanted vaccine exhibit specific inflammatory, Autophagic, and mitochondrial responses","volume":"12","author":"Masson","year":"2024","journal-title":"Toxics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00415-021-10768-3","article-title":"COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis","volume":"269","author":"Faissner","year":"2022","journal-title":"J Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e01475","DOI":"10.1016\/j.idcr.2022.e01475","article-title":"Fasciitis of the lower leg after COVID-19 vaccination","volume":"28","author":"Ide","year":"2022","journal-title":"IDCases"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","article-title":"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","volume":"23","author":"Fourati","year":"2022","journal-title":"Nat Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e35865","DOI":"10.1097\/MD.0000000000035865","article-title":"Isaacs syndrome with LGI1 and CASPR2 antibodies after HPV vaccination: a case report","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3346\/jkms.2021.36.e288","article-title":"Ischemic stroke of the Corpus callosum after SARS-CoV-2 vaccination","volume":"36","author":"Finsterer","year":"2021","journal-title":"J Korean Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/vaccines11030665","article-title":"New-onset arthritis following COVID-19 vaccination: a systematic review of case reports","volume":"11","author":"Liu","year":"2023","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"108765","DOI":"10.1016\/j.clim.2021.108765","article-title":"Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus systemic lupus erythematosus","volume":"229","author":"Ntouros","year":"2021","journal-title":"Clin Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7197\/cmj.1035772","article-title":"Oxidative stress and menstrual complications caused by vaccination of COVID-19 among females athletes","volume":"44","author":"Khan","year":"2022","journal-title":"Cumhuriyet Med J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1560973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:43:27Z","timestamp":1746186207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1560973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2025.1560973"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1560973","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1560973"}}